GSP Crop Science Ltd Q2 FY2027 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/qei76zlxxsrkk1n8vc65blkq.pdf

Key Takeaways


Top-Line Growth & Its Composition

Shail Shah: "So currently exports is almost 20% of our total business. And we see that going forward in the 3 years' time, this could go up to 25% with -- as the growth is also being planned for the domestic business, proportionately we see that there will be growth in domestic also."

Margin Pressure: Causes & Recovery Path

Shail Shah: "So we see that another quarter or so, we see that it could be, where there could be certain pressures further. But I think in the Q4, we could see that the margins again coming up back to the normal levels."

Monsoon, Farmer Behavior & Near-Term Demand

Shail Shah: "So there, once a crop is 45 days-50 days old and the farmer is a bit confident that now the crop will survive, there the farmer is inclined to spend towards crop protection because that is how we can save or increase his yield. But if there are any chances where they see that in the early stages where because of a huge gap or a deficit in the early days where the rain is not sufficient, then the farmers are a bit reluctant to use that because they don't see that visibility of the crop surviving the entire cycle."

International Expansion: Brazil & Latin America

Shail Shah: "2 years-3 years timeline, we see that we will be doing sizable business in this geography once you have acquired decent number of registrations with a good enough variability in the portfolio that we have to offer to that market."

Product Strategy & Differentiation

Shail Shah: "So we try to create a unique combination of formulation from the existing and the newer chemistries that are available. And we try to patent them. ... these patented combinations help the farmers to solve multiple problems by using one product. And it helps us to create a niche in that market where we are able to differentiate from other existing products or generics that are there."

Guidance & Commitments

CommitmentSpecificsTimeline
Margin normalizationMargins to return to normal levels, driven by improved realizations and pre-placement periodQ4 FY27
Sequential EBITDA improvementEBITDA margins to improve sequentially in coming quarters, supported by Rabi products and Q4 pre-placementQ3 and Q4 FY27
Q4 better than Q3Both PAT and EBITDA margins confirmed to be better in Q4 than Q3Q4 FY27
Rabi performanceDo at least better than last year in Rabi season despite macro challengesRabi season
Export contributionExport share of total revenue to increase from ~20% to 25%3 years
Brazil sizable businessAchieve meaningful revenue in Brazil once sufficient registrations and portfolio variability are in place2–3 years
Brazil platform scalingSet up a platform to scale in Brazil and expand to other Latin American countriesAt least 1–2 years
Latin America export contributionLatin America to contribute a good portion of export business2–3 years
International patent registrationsRegistrations with IPR protection to come through in international markets2–3 years
R&D investment increaseR&D spend to increase to support product development and backward integrationLikely from next year onward

Key Metrics

MetricQ2 FY27
Revenue from operations₹558 cr, +19.5% YoY
H1 FY27 revenue from operations₹944 cr, +12% YoY
EBITDA₹73.6 cr, -21% YoY from ₹93.2 cr
EBITDA margin13.2%, vs 13.2% in Q2 FY26 (Q2 FY26 EBITDA margin not stated on these pages)
H1 FY27 EBITDA margin12.3%
Profit after tax₹44.6 cr, vs ₹58.5 cr in Q2 FY26
H1 FY27 profit after tax₹71 cr
Gross profit margin34%, declined from 40% (40% figure stated by analyst, not confirmed by management on these pages)
Export revenue contribution~20% of total business
R&D investment~2.5% of revenue
Raw material imported40% to 45% of total requirement, from China
Normalized other income~₹2 cr per quarter, excluding asset sales
Cumulative rainfall (IMD)~87% of long period average, lowest since 2015